Síndromes Linfoproliferativos Post Transplante
Síndromes Linfoproliferativos Post Transplante
Síndromes Linfoproliferativos Post Transplante
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
18<br />
Trappe RU, Choquet S, Reinke P, Dreyling M, Mergenthaler HG, Jager U, Kebelmann-Betzing C,<br />
Jonas S, Lehmkuhl H, Anagnostopoulos I, Leblond V, Hetzer R, Dorken B, Riess H, Oertel S:<br />
Salvage therapy for relapsed posttransplant lymphoproliferative disorders (PTLD) with a second<br />
progression of PTLD after Upfront chemotherapy: the role of single-agent rituximab.<br />
Transplantation 2007;84:1708-1712.<br />
19Hayashida M, Ogita K, Matsuura T, Takahashi Y, Nishimoto Y, Ohga S, Hara T, Soejima Y,<br />
Taketomi A, Maehara Y, Kohashi K, Tsuneyoshi M, Taguchi T: Successful prolonged rituximab<br />
treatment for post-transplant lymphoproliferative disorder following living donor liver<br />
transplantation in a child. Pediatr Transplant 2007;11:671-675.<br />
20<br />
Lee JJ, Lam MS, Rosenberg A: Role of chemotherapy and rituximab for treatment of<br />
posttransplant lymphoproliferative disorder in solid organ transplantation. Ann Pharmacother<br />
2007;41:1648-1659.<br />
21<br />
van de Glind G, de Graaf S, Klein C, Cornelissen M, Maecker B, Loeffen J: Intrathecal rituximab<br />
treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous<br />
system. Pediatr Blood Cancer 2008;50:886-888.<br />
Page 30 of 30
Change language